China Progesterone formulation Factory

Sticking to the perception of "Creating products of top of the range and earning mates with people today from all over the world", we constantly put the desire of consumers in the first place for Progesterone formulation,CAS NO 57-83-0,57-83-0,Progesterone soft capsules,Progesterone Capsules, We sincerely welcome mates to negotiate organization and start cooperation. We hope to affix hands with good friends in different industries to produce a fantastic long term.
Progesterone formulation, In order to make more people know our items and to enlarge our market, we've got devoted a lot of attention to technical innovations and improvement, as well as replacement of equipment. Last but not the least, we also pay more attention to training our managerial personnel, technicians and workers in planned way.

Hot Products

  • Difelikefalin

    Difelikefalin

    Product Name:Difelikefalin
    Molecular Formula:C36H53N7O6
    Molecular Weight;679.85
    CAS Registry Number;1024828-77-0
  • Ozagrel hydrochloride

    Ozagrel hydrochloride

    Product Name:Ozagrel hydrochloride
    Molecular Formula:C13H13ClN2O2
    Molecular Weight;264.71
    CAS Registry Number;78712-43-3
  • Tetraethyl ranelate

    Tetraethyl ranelate

    Product Name:Tetraethyl ranelate
    Molecular Formula:C20H26N2O8S
    Molecular Weight:454.49
    CAS Registry Number:58194-26-6
  • 2’,3’,5’-Triacetyluridine

    2’,3’,5’-Triacetyluridine

    Product Name:2’,3’,5’-Triacetyluridine
    Molecular Formula:C15H18N2O9
    Molecular Weight:370.31
    CAS Registry Number:4105-38-8
  • Norfloxacin Capsules

    Norfloxacin Capsules

    Product Name:Norfloxacin Capsules
    Dosage:0.1g
    Application:Antibiotic
  • Calcipotriol Monohydrate

    Calcipotriol Monohydrate

    Product Name:Calcipotriol Monohydrate
    Molecular Formula:C27H42O4
    Molecular Weight;430.63
    CAS Registry Number;147657-22-5

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept